Urologix loses round in patent suit against ProstaLund
This article was originally published in Clinica
Executive Summary
Minneapolis, Minnesota-based Urologix has had a patent overturned by a US district court in Wisconsin as part of a dispute over microwave treatments for benign prostatic hyperplasia.